MARKET

ANRO

ANRO

Alto Neuroscienc
NYSE
32.30
+3.12
+10.69%
After Hours: 31.87 -0.43 -1.33% 19:37 08/13 EDT
OPEN
30.00
PREV CLOSE
29.18
HIGH
33.67
LOW
29.59
VOLUME
989.94K
TURNOVER
--
52 WEEK HIGH
33.67
52 WEEK LOW
3.020
MARKET CAP
1.25B
P/E (TTM)
-13.1934
1D
5D
1M
3M
1Y
5Y
1D
Alto Neuroscience, Inc. (ANRO) Receives a Buy from Jefferies
TipRanks · 8h ago
Alto Neuroscience Price Target Raised to $26.00/Share From $24.00 by Wedbush
Dow Jones · 10h ago
Alto Neuroscience Is Maintained at Neutral by Wedbush
Dow Jones · 10h ago
Wedbush Maintains Neutral on Alto Neuroscience, Raises Price Target to $26
Benzinga · 10h ago
Analyst Lifts ALTO-207 Price Target to $37 on Strong TRD Profile and Expanded Monotherapy Strategy, Reiterates Buy
TipRanks · 13h ago
Alto Neuroscience Is Maintained at Buy by BTIG
Dow Jones · 13h ago
Alto Neuroscience Price Target Raised to $37.00/Share From $28.00 by BTIG
Dow Jones · 13h ago
BTIG Maintains Buy on Alto Neuroscience, Raises Price Target to $37
Benzinga · 13h ago
More
About ANRO
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company focused on redefining psychiatry by leveraging neurobiology to develop personalized and effective treatment options. The Company's Precision Psychiatry Platform measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to identify which patients are likely to respond to its product candidates. Its clinical-stage pipeline includes drug candidates in bipolar depression, major depressive disorder, treatment resistant depression (TRD), and schizophrenia, and other mental health conditions. Its product candidates include ALTO-100, ALTO-300, ALTO-207, ALTO-203, ALTO-101, ALTO-202, and ALTO-208. ALTO-100 is a first-in-class, oral small molecule believed to work through enhancing neural plasticity in the hippocampus, a brain region important for both cognition and mood. ALTO-203 is an oral small molecule histamine H3 receptor inverse agonist.

Webull offers Alto Neuroscience Inc stock information, including NYSE: ANRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANRO stock methods without spending real money on the virtual paper trading platform.